Melissa G. Mccracken
1015 Arlington Street
Winnipeg, MB, Canada
Winnipeg, MB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2025
Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 17 years of the CANWARD study (2007-23).
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2025
Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23).
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2025
Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23.
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2025
Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2025
Enterococcus faecium harbouring vanA, optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance case.
Journal: The Journal of antimicrobial chemotherapy
Published: July 30, 2025
Presence of the narrow-spectrum OXA-1 β-lactamase enzyme is associated with elevated piperacillin/tazobactam MIC values among ESBL-producing Escherichia coli clinical isolates (CANWARD, 2007-18).
Journal: JAC-antimicrobial resistance
Published: March 24, 2022
Vancomycin-resistant Enterococcus sequence type 1478 spread across hospitals participating in the Canadian Nosocomial Infection Surveillance Program from 2013 to 2018.
Journal: Infection control and hospital epidemiology
Published: March 10, 2022
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
Journal: The Journal of antimicrobial chemotherapy
Published: April 08, 2021
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
Journal: The Journal of antimicrobial chemotherapy
Published: April 07, 2021
Emergence of pstS-Null Vancomycin-Resistant Enterococcus faecium Clone ST1478, Canada, 2013-2018.
Journal: Emerging infectious diseases
Published: August 21, 2020
Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
Journal: The Journal of antimicrobial chemotherapy
Published: September 11, 2019
Last Updated: 09/26/2026